• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CUV 2.80% $14.57

CLINUVEL PHARMACEUTICALS LIMITED

Clinuvel Pharmaceuticals Limited is a global specialty pharmaceutical company. The... Clinuvel Pharmaceuticals Limited is a global specialty pharmaceutical company. The Company is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. The Company is engaged in managing and expanding commercial distribution of its lead drug candidate, SCENESSE, in Europe, the United States, Israel, and Australia for the treatment of a rare, genetic metabolic disorder, erythropoietic protoporphyria (EPP). The Company’s pipeline includes PRENUMBRA, NEURACTHEL, CUV9900, and Parvysmelanotide (VLRX001). PRENUMBRA is a liquid (non-solid) injectable formulation of afamelanotide designed to provide a flexible dose of afamelanotide, a synthetic analogue of natural a-melanocyte stimulating hormone. NEURACTHEL is a novel formulation of the melanocortin adrenocorticotropic hormone (ACTH), for neurological, endocrinological and degenerative disorders.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CUV
Shorts - general info
11 12 13
27/04/24 749 288K
27/04/24 Last post  cyprus Comments Created with Sketch.  749  Views Created with Sketch.  288K 
CUV
Buy Back
26/04/24 5 1.4K
26/04/24 Last post  geffa9 Comments Created with Sketch.  5  Views Created with Sketch.  1.4K 
CUV 26/04/24 2 780
26/04/24 Last post  LJSM Comments Created with Sketch.  2  Views Created with Sketch.  780 
CUV 23/04/24 10 3.6K
23/04/24 Last post  ben1976 Comments Created with Sketch.  10  Views Created with Sketch.  3.6K 
CUV
Recent Departures
22/04/24 13 4.4K
22/04/24 Last post  Melon felon! Comments Created with Sketch.  13  Views Created with Sketch.  4.4K 
CUV 17/04/24 7 2.7K
17/04/24 Last post  Epichemist Comments Created with Sketch.  7  Views Created with Sketch.  2.7K 
CUV
Clinuvel and Hedge Fund Manipulation
16/04/24 18 5.7K
16/04/24 Last post  Melon felon! Comments Created with Sketch.  18  Views Created with Sketch.  5.7K 
CUV
News: CUV Clinuvel Pharmaceuticals Says CFO Darren Keamy Will Conclude Role On 30 June 2024
15/04/24 0 225
15/04/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  225 

See All Discussions arrow Created with Sketch.

Timeline

Ceasing to be a substantial holder
26 Apr 08:19
 
CLINUVEL expands global leadership team
22 Apr 09:27
 
Change to executive management
15 Apr 10:01
 
Update - Notification of buy-back - CUV
12 Apr 09:04
 
Update - Notification of buy-back - CUV
10 Apr 09:16
 
Update - Notification of buy-back - CUV
09 Apr 09:02
 
View More arrow Created with Sketch.
(20min delay)
Last
$14.57
Change
-0.420(2.80%)
Mkt cap ! $730.3M
Open High Low Value Volume
$15.02 $15.20 $14.56 $799.8K 54.61K

Buyers (Bids)

No. Vol. Price($)
1 304 $14.57
 

Sellers (Offers)

Price($) Vol. No.
$14.63 1 1
View Market Depth
Last trade - 16.10pm 26/04/2024 (20 minute delay) ?
Last
$14.61
  Change
-0.420 ( 3.01 %)
Open High Low Volume
$14.78 $14.85 $14.57 4835
Last updated 15.59pm 26/04/2024 ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.